![C. elegans maximum velocity correlates with healthspan and is maintained in worms with an insulin receptor mutation | Nature Communications C. elegans maximum velocity correlates with healthspan and is maintained in worms with an insulin receptor mutation | Nature Communications](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fncomms9919/MediaObjects/41467_2015_Article_BFncomms9919_Fig1_HTML.jpg)
C. elegans maximum velocity correlates with healthspan and is maintained in worms with an insulin receptor mutation | Nature Communications
![Kinetic analysis reveals that independent nucleation events determine the progression of polyglutamine aggregation in C. elegans | PNAS Kinetic analysis reveals that independent nucleation events determine the progression of polyglutamine aggregation in C. elegans | PNAS](https://www.pnas.org/content/118/11/e2021888118/F1.large.jpg)
Kinetic analysis reveals that independent nucleation events determine the progression of polyglutamine aggregation in C. elegans | PNAS
![The cellular modifier MOAG‐4/SERF drives amyloid formation through charge complementation | The EMBO Journal The cellular modifier MOAG‐4/SERF drives amyloid formation through charge complementation | The EMBO Journal](https://www.embopress.org/cms/asset/0a00209b-b377-4db0-8364-6e7fa87dfb44/embj2020107568-abs-0001-m.jpg)
The cellular modifier MOAG‐4/SERF drives amyloid formation through charge complementation | The EMBO Journal
![The cellular modifier MOAG‐4/SERF drives amyloid formation through charge complementation | The EMBO Journal The cellular modifier MOAG‐4/SERF drives amyloid formation through charge complementation | The EMBO Journal](https://www.embopress.org/cms/asset/39e32169-2507-4ecd-951c-bf345ae4c782/embj2020107568-fig-0005-m.jpg)
The cellular modifier MOAG‐4/SERF drives amyloid formation through charge complementation | The EMBO Journal
![MOAG-4 promotes the aggregation of α-synuclein by competing with self-protective electrostatic interactions - Journal of Biological Chemistry MOAG-4 promotes the aggregation of α-synuclein by competing with self-protective electrostatic interactions - Journal of Biological Chemistry](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/1e415ef4-84ba-409e-b7e7-8bb8927859a0/gr2.jpg)
MOAG-4 promotes the aggregation of α-synuclein by competing with self-protective electrostatic interactions - Journal of Biological Chemistry
![Frontiers | In vivo Pooled Screening: A Scalable Tool to Study the Complexity of Aging and Age-Related Disease | Aging Frontiers | In vivo Pooled Screening: A Scalable Tool to Study the Complexity of Aging and Age-Related Disease | Aging](https://www.frontiersin.org/files/Articles/714926/fragi-02-714926-HTML/image_m/fragi-02-714926-g003.jpg)
Frontiers | In vivo Pooled Screening: A Scalable Tool to Study the Complexity of Aging and Age-Related Disease | Aging
![Genome-wide RNA interference screen identifies previously undescribed regulators of polyglutamine aggregation | PNAS Genome-wide RNA interference screen identifies previously undescribed regulators of polyglutamine aggregation | PNAS](https://www.pnas.org/content/pnas/101/17/6403/F2.large.jpg)
Genome-wide RNA interference screen identifies previously undescribed regulators of polyglutamine aggregation | PNAS
![Protective role of DNJ-27/ERdj5 in Caenorhabditis elegans models of human neurodegenerative diseases. - Abstract - Europe PMC Protective role of DNJ-27/ERdj5 in Caenorhabditis elegans models of human neurodegenerative diseases. - Abstract - Europe PMC](https://europepmc.org/articles/PMC3887457/bin/fig-7.jpg)
Protective role of DNJ-27/ERdj5 in Caenorhabditis elegans models of human neurodegenerative diseases. - Abstract - Europe PMC
![Identification of an evolutionary conserved structural loop that is required for the enzymatic and biological function of tryptophan 2,3-dioxygenase | Scientific Reports Identification of an evolutionary conserved structural loop that is required for the enzymatic and biological function of tryptophan 2,3-dioxygenase | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsrep39199/MediaObjects/41598_2016_Article_BFsrep39199_Fig1_HTML.jpg)
Identification of an evolutionary conserved structural loop that is required for the enzymatic and biological function of tryptophan 2,3-dioxygenase | Scientific Reports
![Frontiers | A Novel Hybrid Model for Drawing Trace Reconstruction from Multichannel Surface Electromyographic Activity | Neuroscience Frontiers | A Novel Hybrid Model for Drawing Trace Reconstruction from Multichannel Surface Electromyographic Activity | Neuroscience](https://www.frontiersin.org/files/MyHome%20Article%20Library/243156/243156_Thumb_400.jpg)
Frontiers | A Novel Hybrid Model for Drawing Trace Reconstruction from Multichannel Surface Electromyographic Activity | Neuroscience
![Protective role of DNJ-27/ERdj5 in Caenorhabditis elegans models of human neurodegenerative diseases. - Abstract - Europe PMC Protective role of DNJ-27/ERdj5 in Caenorhabditis elegans models of human neurodegenerative diseases. - Abstract - Europe PMC](https://europepmc.org/articles/PMC3887457/bin/fig-4.jpg)
Protective role of DNJ-27/ERdj5 in Caenorhabditis elegans models of human neurodegenerative diseases. - Abstract - Europe PMC
![Protective role of DNJ-27/ERdj5 in Caenorhabditis elegans models of human neurodegenerative diseases. - Abstract - Europe PMC Protective role of DNJ-27/ERdj5 in Caenorhabditis elegans models of human neurodegenerative diseases. - Abstract - Europe PMC](https://europepmc.org/articles/PMC3887457/bin/fig-2.jpg)
Protective role of DNJ-27/ERdj5 in Caenorhabditis elegans models of human neurodegenerative diseases. - Abstract - Europe PMC
![The cellular modifier MOAG‐4/SERF drives amyloid formation through charge complementation | The EMBO Journal The cellular modifier MOAG‐4/SERF drives amyloid formation through charge complementation | The EMBO Journal](https://www.embopress.org/cms/asset/abae4768-ad16-4575-bb98-e8a511fd337f/embj2020107568-fig-0007-m.jpg)
The cellular modifier MOAG‐4/SERF drives amyloid formation through charge complementation | The EMBO Journal
![Age‐ and disease‐specific changes of the kynurenine pathway in Parkinson's and Alzheimer's disease - Sorgdrager - 2019 - Journal of Neurochemistry - Wiley Online Library Age‐ and disease‐specific changes of the kynurenine pathway in Parkinson's and Alzheimer's disease - Sorgdrager - 2019 - Journal of Neurochemistry - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/16c26bf4-0faf-4088-ae08-a51727c8af2b/jnc14843-fig-0004-m.png)
Age‐ and disease‐specific changes of the kynurenine pathway in Parkinson's and Alzheimer's disease - Sorgdrager - 2019 - Journal of Neurochemistry - Wiley Online Library
![Neurodegenerative diseases: Lessons from genome‐wide screens in small model organisms | EMBO Molecular Medicine Neurodegenerative diseases: Lessons from genome‐wide screens in small model organisms | EMBO Molecular Medicine](https://www.embopress.org/cms/asset/d9853ff4-b59e-4880-9cdb-3dd0de5cb19a/emmm200900051-fig-002-m.jpg)
Neurodegenerative diseases: Lessons from genome‐wide screens in small model organisms | EMBO Molecular Medicine
![Frontiers | Membrane Interactions and Toxicity by Misfolded Protein Oligomers | Cell and Developmental Biology Frontiers | Membrane Interactions and Toxicity by Misfolded Protein Oligomers | Cell and Developmental Biology](https://www.frontiersin.org/files/Articles/642623/fcell-09-642623-HTML/image_m/fcell-09-642623-g001.jpg)
Frontiers | Membrane Interactions and Toxicity by Misfolded Protein Oligomers | Cell and Developmental Biology
![Serum tryptophan decrease correlates with immune activation and impaired quality of life in colorectal cancer | British Journal of Cancer Serum tryptophan decrease correlates with immune activation and impaired quality of life in colorectal cancer | British Journal of Cancer](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fsj.bjc.6600336/MediaObjects/41416_2002_Article_BF6600336_Fig1_HTML.gif)
Serum tryptophan decrease correlates with immune activation and impaired quality of life in colorectal cancer | British Journal of Cancer
![Protective role of DNJ-27/ERdj5 in Caenorhabditis elegans models of human neurodegenerative diseases. - Abstract - Europe PMC Protective role of DNJ-27/ERdj5 in Caenorhabditis elegans models of human neurodegenerative diseases. - Abstract - Europe PMC](https://europepmc.org/articles/PMC3887457/bin/fig-3.jpg)
Protective role of DNJ-27/ERdj5 in Caenorhabditis elegans models of human neurodegenerative diseases. - Abstract - Europe PMC
![Protective role of DNJ-27/ERdj5 in Caenorhabditis elegans models of human neurodegenerative diseases. - Abstract - Europe PMC Protective role of DNJ-27/ERdj5 in Caenorhabditis elegans models of human neurodegenerative diseases. - Abstract - Europe PMC](https://europepmc.org/articles/PMC3887457/bin/fig-5.jpg)
Protective role of DNJ-27/ERdj5 in Caenorhabditis elegans models of human neurodegenerative diseases. - Abstract - Europe PMC
![Protective role of DNJ-27/ERdj5 in Caenorhabditis elegans models of human neurodegenerative diseases. - Abstract - Europe PMC Protective role of DNJ-27/ERdj5 in Caenorhabditis elegans models of human neurodegenerative diseases. - Abstract - Europe PMC](https://europepmc.org/articles/PMC3887457/bin/fig-1.jpg)